We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
75 hedge funds and large institutions have $1.25B invested in Kymera Therapeutics in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
144% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 16
130% more capital invested
Capital invested by funds: $542M → $1.25B (+$705M)
44% more funds holding
Funds holding: 52 → 75 (+23)
7.79% more ownership
Funds ownership: 37.87% → 45.66% (+7.8%)
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
Holders
75
Holders Change
+23
Holders Change %
+44.23%
% of All Funds
1.33%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.07%
New
39
Increased
13
Reduced
13
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$31.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.81M |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.83M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.66M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.6M |
